People Background Check
Find People:

Lisa Ellen Danzig, Age 601370 Church St, San Francisco, CA 94114

Get Report
Known as:
Lisa E Danzig Lisa Ellen Da Allison
Related to:
Leda Danzig 88 Ronald I Danzig 91

Lisa Danzig Phones & Addresses

1370 Church St, San Francisco, CA 94114 (415) 282-2295

Boston, MA

Atlanta, GA

Portland, OR

Somerville, MA

1370 Church St, San Francisco, CA 94114

Work

Position: Medical Professional

Education

School / High School: Oregon Health Sciences University 1990

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Infectious Disease, 1996

Emails

l***[email protected]

Mentions for Lisa Ellen Danzig

Career records & work history

Medicine Doctors

Lisa Danzig Photo 1

Dr. Lisa E Danzig, San Francisco CA - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
1370 Church St, San Francisco, CA 94114
Certifications:
Infectious Disease, 1996
Internal Medicine, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Oregon Health Sciences University
Graduated: 1990
Medical School
Pacific Presby Mc
Graduated: 1990
Medical School
Cdc
Graduated: 1990
Medical School
Ucsf-Mt Zion Hosp
Graduated: 1990
Lisa Danzig Photo 2

Lisa Ellen Danzig, Emeryville CA

Specialties:
Internal Medicine
Infectious Disease
Work:
Novartis Vaccines & Dgnstcs
4560 Horton St, Emeryville, CA 94608
Education:
Oregon Health & Science University (1990)

Lisa Danzig resumes & CV records

Resumes

Lisa Danzig Photo 21

Co-Founder And Managing Partner

Location:
900 Veterans Blvd, Redwood City, CA 94063
Industry:
Biotechnology
Work:
Payssurance
Director Paxvax, Inc. Oct 2017 - Oct 2018
Chief Medical Officer Amicitiam Partners Oct 2017 - Oct 2018
Co-Founder and Managing Partner The Batchery May 2015 - Jan 2018
Advisor Paxvax, Inc. Jun 1, 2015 - Sep 2017
Vice President, Clinical Development and Medical Affairs Healthexpense, Inc. 2010 - Dec 2015
Advisor Grifols Jan 2014 - Feb 2015
Global Head Medical and Scientific Affairs Orsense Jan 2014 - Feb 2015
Independent Director Novartis Mar 2011 - Jan 2014
Global Head Medical and Scientific Affairs Novartis Aug 2010 - Mar 2013
Global Head, Clinical Affairs The Lemelson Foundation Aug 2010 - Mar 2013
Advisory Committee Member Novartis Dec 2009 - Aug 2010
Head Development Transformation Team, China Novartis Nov 2008 - Dec 2009
Senior Director, Head Licensing Clinical Evaluation Novartis 2007 - 2008
Senior Director, Head Early Development Cluster Chiron Corporation 1997 - 2006
Clinical Development Cdc 1993 - 1995
Eis Officer, Hospital Infections Program, Ncid
Education:
Oregon Health and Science University School of Medicine 1986 - 1990
Doctor of Medicine, Doctorates, Medicine Reed College 1981 - 1985
Bachelors, Bachelor of Arts, Biology Phillips Exeter Academy
Skills:
Clinical Development, Biotechnology, Drug Development, Clinical Trials, Infectious Diseases, Vaccines, Pharmaceutical Industry, Clinical Research, Lifesciences, Gcp, Pharmaceutics, Immunology, Oncology, Biopharmaceuticals, Medical Writing, Drug Discovery, Life Sciences, Pharmacovigilance, Commercialization, Regulatory Submissions, Technology Transfer, Product Launch, Medical Devices, Fda, Sop, Regulatory Affairs, Cro, Molecular Biology, Validation, Due Diligence, Medicine, Cross Functional Team Leadership, Strategy, Management, Cell Culture, Microbiology, 21 Cfr Part 11, Capa, Leadership, Medical Diagnostics, R&D, Medical Affairs
Interests:
Environment
Arts and Culture
Languages:
Italian
French
English
Lisa Danzig Photo 22

Lisa Danzig

Lisa Danzig Photo 23

Lisa Danzig

Lisa Danzig Photo 24

Lisa Danzig

Lisa Danzig Photo 25

Lisa Danzig

Location:
San Francisco, CA
Industry:
Biotechnology

Publications & IP owners

Us Patents

Regimens For Immunisation With Meningococcal Conjugates

US Patent:
2009009, Apr 16, 2009
Filed:
Oct 6, 2008
Appl. No.:
12/287225
Inventors:
Lisa Danzig - San Francisco CA, US
International Classification:
A61K 39/385
US Classification:
42419711
Abstract:
Multivalent meningococcal conjugate vaccines are administered according to a schedule in which at least one or two doses are administered to a patient aged between 0 and 12 months, and a further dose is administered to a patient aged between 12 and 24 months.

Regimens For Immunisation With Meningococcal Conjugates

US Patent:
2009029, Dec 3, 2009
Filed:
Mar 22, 2007
Appl. No.:
12/225501
Inventors:
Lisa Danzig - San Francisco CA, US
International Classification:
A61K 39/095
US Classification:
42419711
Abstract:
Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.

Regimens For Immunisation With Meningococcal Conjugates

US Patent:
2008002, Jan 31, 2008
Filed:
Mar 22, 2007
Appl. No.:
11/726656
Inventors:
Lisa Danzig - San Francisco CA, US
International Classification:
A61K 39/385
A61P 31/04
US Classification:
424197110
Abstract:
Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.

Regimens For Immunisation With Meningococcal Conjugates

US Patent:
2021006, Mar 4, 2021
Filed:
Oct 28, 2020
Appl. No.:
17/082415
Inventors:
- Rixensart, BE
Lisa DANZIG - San Francisco CA, US
Assignee:
GLAXOSMITHKLINE BIOLOGICALS SA - Rixensart
International Classification:
A61K 39/095
Abstract:
Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.

Regimens For Immunisation With Meningococcal Conjugates

US Patent:
2020013, May 7, 2020
Filed:
Dec 17, 2019
Appl. No.:
16/716638
Inventors:
- Rixensart, BE
Lisa DANZIG - San Francisco CA, US
Assignee:
GLAXOSMITHKLINE BIOLOGICALS SA - Rixensart
International Classification:
A61K 39/095
Abstract:
Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.

Possible Relatives

David M Danzig  Aaron Danzig  Delia W Danzig  Fred G Danzig  Howard S Danzig  Kevin R Danzig  Richard W Danzig  Lisa M Last  Lisa Johnson  Lisa L Standiford 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.